Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B

BACKGROUND/AIMS: Quantitation of hepatitis B surface antigen (HBsAg) is an increasingly popular method to determine the treatment response in chronic hepatitis B (CHB) patients. The clinical value of HBsAg level measurement during rescue therapy for lamivudine (LMV)-resistant CHB patients have not b...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kim, Jeong Han, Moon, Hee Won, Ko, Soon Young, Choe, Won Hyeok, Kwon, So Young
Format: Artigo
Idioma:Inglês
Publicat: The Korean Association for the Study of the Liver 2014
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4197176/
https://ncbi.nlm.nih.gov/pubmed/25320731
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2014.20.3.274
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars